AGP
AGP (AGP) is a company in Vietnam's Health Care sector, listed on UPCOM. The stock last traded at 27,200 VND, little changed on the session, giving a market capitalization of 1.2 trillion VND.
On valuation, AGP trades at a price-to-earnings ratio of 22.9 and a price-to-book of 2.1. That is a premium to the Health Care sector average P/E of 18.9. Return on equity of 9.3% points to modest profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 1,465 VND.
Aveluro tracks 1 news item mentioning AGP, where recent coverage skews mixed (100% of articles). The most recent catalyst was an earnings inline event — "Agimexpharm (AGP) reported Q2 net profit up 23% YoY to 15.8 billion VND, but operating cash flow turned deeply negative at -142.5 billion VND due to rising receivables and inventory, while cash dropped 75%.". Aveluro's composite model rates AGP 5.9/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AMP, AMV and APC.
Agimexpharm (AGP) reported Q2 net profit up 23% YoY to 15.8 billion VND, but operating cash flow turned deeply negative at -142.5 billion VND due to rising receivables and inventory, while cash dropped 75%.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this